Last filing: Apr 28, 2026. Most recent sale before this period: Dec 9, 2021. Most recent purchase on record: Oct 23, 2023.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Dec 9, 2021.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Abbott Laboratories (ABT) | Director | May 2, 2023 | Apr 28, 2026 |
| Northern Trust (NTRS) | Chairman and CEO, Director | Aug 16, 2011 | Mar 4, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Apr 24, 2026, Abbott Laboratories: 2,286 shares granted. 1 filing: 1
- Mar 1, 2026, Northern Trust: 11,129 shares withheld by the company for taxes. 1 filing: 1
- Feb 17, 2026, Northern Trust: 72,642 shares awarded; 32,181 shares withheld by the company for taxes. 1 filing: 1
- Feb 5, 2026, Northern Trust: 19,437 shares awarded. 1 filing: 1
- Jan 29, 2026, Northern Trust: 34,489 shares acquired by exercising options; 21,739 shares withheld by the company for taxes (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.